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Abstract
Background: The mucosal tissues play a central role in the transmission of HIV-1 infection as well as in the pathogenesis of
AIDS. Despite several clinical studies reported intestinal dysfunction during HIV infection, the mechanisms underlying HIV-
induced impairments of mucosal epithelial barrier are still unclear. It has been postulated that HIV-1 alters enterocytic
function and HIV-1 proteins have been detected in several cell types of the intestinal mucosa. In the present study, we
analyzed the effect of the accessory HIV-1 Nef protein on human epithelial cell line.
Methodology/Principal Findings: We used unstimulated or IFN-c-stimulated Caco-2 cells, as a model for homeostatic and
inflamed gastrointestinal tracts, respectively. We investigated the effect of exogenous recombinant Nef on monolayer
integrity analyzing its uptake, transepithelial electrical resistance, permeability to FITC-dextran and the expression of tight
junction proteins. Moreover, we measured the induction of proinflammatory mediators. Exogenous Nef was taken up by
Caco-2 cells, increased intestinal epithelial permeability and upset the IFN-c-induced reduction of transepitelial resistance,
interfering with tight junction protein expression. Moreover, Nef inhibited IFN-c-induced apoptosis and up-regulated TNF-a,
IL-6 and MIP-3a production by Caco-2 cells while down-regulated IL-10 production. The simultaneous exposure of Caco-2
cells to Nef and IFN-c did not affect cytokine secretion respect to untreated cells. Finally, we found that Nef counteracted
the IFN-c induced arachidonic acid cascade.
Conclusion/Significance: Our findings suggest that exogenous Nef, perturbing the IFN-c-induced impairment of intestinal
epithelial cells, could prolong cell survival, thus allowing for accumulation of viral particles. Our results may improve the
understanding of AIDS pathogenesis, supporting the discovery of new therapeutic interventions.
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Introduction
The gastrointestinal (GI) tract represents the largest mucosal
surface in the human body. Mucosal surfaces are separated from
the outside world by epithelial barriers. By blocking the passive
movement of commensal bacteria, pathogens and toxins into the
subepithelial environment, epithelial cells (EC) prevent the onset of
local and systemic inflammation and provide a first line of defence
against infection. The gut barrier is formed by tight junctions (TJ)
linking adjacent EC. TJ disruption can cause increased perme-
ability, leading to inflammatory conditions in the mucosa [1].
Pathological changes in the GI tract represent a characteristic
feature of HIV infection. More than 85% of HIV infections are
acquired by mucosal transmission, and quantitative and qualitative
defects of mucosal immunity are present in all stages of infection [2].
The GI tract is a major site of HIV replication, resulting in massive
depletion of lamina propria CD4
+ T cells during acute infection.
Chronic HIV infection is characterized by increased intestinal
permeability and enteropathy, and chronicactivation ofthe immune
system,whichisasignificantpredictorofdiseaseprogression.During
the progression of the disease, chronic diarrhoea, dehydration, and
malabsorption, lead to progressive weight loss, contributing to the
morbidity and mortality of HIV-1
+ subjects [3,4].
The pathophysiology of HIV-1-related intestinal dysfunction
has been attributed to opportunistic infections, cytokine secretion
in response to chronic inflammation, and a direct role of HIV itself
[5,6]. HIV triggers the local release of cytokines that lead to
impairment of barrier function by altering the expression of TJ-
associated proteins and by inducing apoptosis of EC. The resultant
barrier defect facilitates the microbial antigen translocation that
further stimulates mucosal cytokine production and systemic
immune activation [7]. Some effects induced by HIV-1 are
mediated by viral factors, such as gp120 that accelerates human
lamina propria T cell apoptosis [8]. In vitro studies demonstrated
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dysfunction, affecting the uptake of glucose by enterocytes and
causing microtubules depolymerisation [9,10].
HIV-1 Nef protein is an essential factor for efficient viral
replication and pathogenesis [11]. Nef exerts pleiotropic effects
interfering with cellular signal transduction pathways [12]. Nef
targets cell membranes and elicits cytoskeletal rearrangement,
organelle formation and synapse destabilization [13-15]. To date,
most of Nef’s functions have been associated with its biochemical
activities within the producer cell. However, Nef is known to be
secreted from infected cells [16] in association with small
membrane-bound vescicles [17,18]. We have previously demon-
strated that purified exogenous Nef enters in monocyte-derived
dendritic cells (MDDC) inducing their activation. This has a direct
impact on CD4
+ T cell bystander activation and on the impairment
ofCD8
+T and NKcellfunction[19–21].Moreover,exogenousNef
downregulates the induction of specific antibody responses [22].
Despite numerous reports describe how HIV affects mucosal
immunity, the pathobiology of Nef in mucosal dysfunction remains
unknown. In the present study, we investigated the effect of HIV-1
Nef exposure on intestinal epithelial cells, using Caco-2 cell line,
representing the best in vitro model currently available of human
enterocytes able to differentiate spontaneously in long term
culture.
We analyzed the effect of HIV-1 Nef on both monolayer
integrity and induction of proinflammatory mediators. We
demonstrated that exogenous Nef was taken up by Caco-2 cells,
increased intestinal epithelial tight junction permeability and upset
the IFN-c-induced impairment of intestinal epithelial cells.
Materials and Methods
Nef protein
Recombinant HIV-1 Nef (BRU variant) was expressed in E.coli
and purified to homogenity by ionic exchange and size exclusion
chromatography from DIATHEVA s.r.l (Fano-ITALY). The Nef
protein was highly purified (.99%) as assessed by SDS-PAGE,
Western Blotting, and by analytical HPLC. Lyophilized protein
was dissolved in sterile water and aliquots were stored at -70uC.
The biological activity was assessed by induction of phenotypical
and functional activation of MDDC [19]. Endotoxin content of
Nef, determined by Pyrotell Limulus amebocyte Lysate assay
(Cape Cod Inc. Falmouth MA. USA) was ,0.03 unit/ml.
A dose-response titration curve was performed to assess the
optimal concentrations of Nef. In all subsequent experiments Nef
was used at 0.1 mg/ml.
In some experiments Nef was preincubated with 10 mg/ml anti-
Nef monoclonal antibody (mAb) or with 10 mg/ml anti-Tat mAb
(DIATHEVA s.r.l). for 60 min at 37uC. Moreover, to further
exclude any contamination due to bacterial expression or non-
specific effects of Nef, boiled Nef (bNef; 100u C, 10 min) or NefF12
were used as negative controls. The recombinant NefF12 protein
(kindly provided by M. Federico, National AIDS Center, Istituto
Superiore di Sanita `, Rome, Italy), a full-length Nef mutant lacking
the most relevant Nef functions [23,24], was recovered and
purified as previously described [25].
Cell culture supernatants containing Nef were kindly provided
by M. Federico, National AIDS Center, Istituto Superiore di
Sanita `, Rome, Italy. Supernatants were obtained by transfecting
293T cells with either a pcDNA3.1 vector expressing wt Nef HIV-
1, strain NL4-3, or, as control, with the vector alone. Two days
later, the supernatants were collected, clarified, and then subjected
to ten-fold concentration using a Centricon device, cut-off 20 kDa,
and forced dialysis against 16 PBS. The amount of Nef in
concentrated supernatants was estimated by semi-quantitative
anti-Nef Western blot assay against quantified amount of
recombinant Nef, which was carried out as already described [26].
Caco-2 cell monolayers
Caco-2 human colonic carcinoma cells were maintained in 5%
CO2 at 37uC in Dulbecco’s modified essential medium (DMEM,
Lonza, Verviers, Belgium) containing 4.5 g/L glucose, 2 mM L-
glutamine, 50 U/mL penicillin, 50 mg/mL streptomycin, 1%
nonessential amino acids, 1% HEPES and 10% heat-inactivated
fetal bovine serum (FBS, Lonza), as described previously [27].
Cells were allowed to differentiate for 21 days and the medium was
regularly changed three times per week.
Permeability measurement
Caco-2 cells were seeded at a density of 4.4610
4 cells/cm
2 on
polycarbonate inserts (0.4 mm pore diameter, 0.9 cm
2 area). After
21 days differentiated cells were treated from the basolateral
compartment with Nef (0.01-0.1-1 mg/ml), IFN-c (BD Bioscienc-
es, Bedford, MA; 600 U/ml), IFN-c/Nef or with supernatants of
trasfected 293T cells. Boiled Nef (0.1 mg/ml) and NefF12 (0.1 mg/
ml) were used as negative controls.
Fluorescein isothiocyanate-conjugated dextran (FITC-dextran;
MW, 4.4 kd; Sigma, St. Luis, MO) was dissolved in culture
medium and used at a final concentration of 2.2 mg/ml in the
apical cell compartment. After 3 h of incubation the amount of
fluorescence was measured in the basal compartment with a
spectrofluorometer. The excitation and emission wavelengths were
490 and 520 nm, respectively.
Transepithelial electrical resistance of Caco-2 cells
Caco-2 cells were grown and left to differentiate for 21 days on
0.4 mm pore inserts and transepithelial electrical resistance
(TEER) of monolayers was measured using a Millicell-ERS device
(Millipore, Bedford, MA, USA). The results were normalized with
the values of TEER measured before treatment, subtracting from
each point the TEER value of the filter alone. TEER data were
recorded at room temperature 24, 48 and 72 h after treatment
with Nef, IFN-c or their combination.
Western blot analysis
Cells were resuspended into a buffer containing 150 mM NaCl,
0.01% sodium dodecylsulfate (SDS) and 1% Triton X-100 and
then centrifuged for 5 min at 4uC. The protein concentration was
measured by the Laemmli method, using the Bio-Rad protein
assay with BSA as standard (Biorad, Hercules, CA). SDS-
polyacrylamide gel electrophoresis was carried out on 4% stacking
and 7.5% resolving gel. 30 mg of proteins were loaded in each lane
with loading buffer containing 0.1Tris (pH 6.8), 20% glycerol,
10% mercaptoethanol, 4% SDS and 0.2% Bromophenol Blue.
Following electrophoresis, the proteins were transferred to a
nitrocellulose membrane (Biorad). Membranes were blocked for 1
h with 5% non-fat milk in TBST (100 mM NaCl, 5 mM KCl,
100 mM Tris-HCl, pH 7.4 and 0.05% Tween 20) and probed
with primary mouse IgG monoclonal antibody (mAb) against
occludin (clone OC-3F10, Zymed, San Francisco, USA), mouse
IgG mAb against ZO-1 (clone 1/ZO-1, BD Biosciences) or mouse
IgG mAb against cyclooxygenase (COX)-2 (Abcam, Cambridge,
UK) for 24 h at +4uC. Secondary antibody (goat-anti-mouse
conjugated to horse-radish peroxidase HRP; Biorad) was added at
a 1:3000 dilution for 1 h at room temperature. Proteins were
revealed by the chemiluminescence detection kit (Biorad),
according to manufacturer’s instructions. Intensities of protein
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Membranes were stripped and reprobed with primary rabbit mAb
against b-actin (Sigma) and then secondary goat-anti rabbit-HRP
(Biorad).
Fluorescence microscopy
Cellular localization of ZO-1 was assessed by immunofluores-
cence analysis. Caco-2 cells were grown on glass coverslips and
after 21 days cells were treated for 48 h with Nef, IFN-c or IFN-c/
Nef. Cells were then fixed with PBS/3.7% formaldehyde (30 min,
room temperature), permeabilized with 0.5% (v/v) Triton X-100
(Sigma) in PBS (5 min, room temperature) and stained with mouse
anti-ZO-1 mAbs (BD Biosciences) at 37uC for 30 min. Cells were
then incubated with anti-mouse IgG fluorescein-linked whole
antibody (Sigma) at 37uC for 30 min. All samples were mounted
with glycerol:PBS (2:1) and analyzed by fluorescence with a Nikon
Microphot microscope (Carl Zeiss, Germany) using SCANware
(Leica Lasertecnik GMBH) and Photoshop (Adobe Sistems Inc)
software.
Confocal laser scanning microscopy (CLSM)
For Nef entry detection, Caco-2 cells were seeded on polycar-
bonate inserts and after 21 days were treated basolaterally with
biotynilated-Nef (DIATHEVA s.r.l) in the presence or absence of
IFN-c for 1, 3, 6 and 24 h. After treatments the inserts were cut,
washed in PBS, fixed with PBS/3% paraformaldehyde (30 min at
4uC), permeabilized with 0.5% (v/v) Triton X-100 (Sigma) in PBS
(10 min, room temperature). Then, the inserts were stained with
avidin-FITC (BioLegend, San Diego, CA) at 37uC for 30 min. All
samples were finally mounted on the microscope slide with
Vectashield antifade mounting medium containing 49,69-diami-
dino-2-phenylindole (DAPI, Vector Laboratories, Peterborough,
UK). CLSM observations were performed with a Leica TCS SP2
AOBS apparatus, using excitation spectral laser lines at 405 and
488 nm and using the Leica Confocal Software (Leica Lasertech-
nik) and Adobe Photoshop software programs (Adobe system
Incorporated). Several cells were analysed for each labelling
condition and representative results are presented.
Apoptotis detection
Annexin V assay was used to detect Caco-2 cell apoptosis. After
48 h of Nef, IFN-c or IFN-c/Nef treatment, Caco-2 cells were
harvestedand washedtwicewithicecoldPBSandspecificbinding of
FITC-conjugate annexin V/propidium iodide was performed with
an apoptosis detection kit (Bender, Wien, Austria) accordingly to the
manufacturer’s instructions. The cells were then analysed with a
FACScan flow cytometer and CellQuest software (BD Biosciences)
to measure co-staining of annexin V and propidium iodide.
Cytokine ELISA
Supernatants from the basolateral chambers were collected 48 h
after treatment with Nef, IFN-c or their combination and IL-6, IL-
10, TNF-a, MIP-3a and IL-8 secretion was measured by sandwich
ELISA (BD OptEIA, San Diego, CA for IL-6, IL-10, TNF-a;
R&D Systems, Abingdon, UK for MIP-3a; Bender for IL-8)
according to the manufacturer’s instructions.
Cytoplasmic phospholipase A2 (cPLA2) enzyme activity
assay
cPLA2 activity was assessed in Caco-2 cell lysates by the cPLA2
assay kit (Cayman Chemicals, Ann Arbor, MI) according to the
manufacturer’s instructions. In brief, cells were treated with Nef,
IFN-c or INF-c/Nef for 4 h and harvested using a rubber
policeman. The cell pellets were sonicated in cold PBS. 10 ml
sample supernatant and 5 ml assay buffer were well mixed and the
reaction was initiated by adding 200 ml substrate solution to the
wells. After 1 h incubation at room temperature, 10 ml of DTNB/
EGTA was added to each well to stop the reaction. Absorbance
was measured at 414 nm.
Prostaglandin E2 (PGE2) quantification
PGE2 concentration was determined in the culture medium of
differentiated Caco-2 monolayers after 24 h of Nef, IFN-c or INF-
c/Nef treatment. PGE2 levels were determined with a PGE2-
monoclonal enzyme immunoassay kit (Cayman Chemicals)
following the manufacturer’s protocol.
Statistical Analysis
Statistical significance of differences was calculated using a
Student’s t test. A p value of less than 0.05 was considered as
statistically significant.
Results
HIV-1 Nef modulates the permeability of intestinal
epithelial monolayers
Since HIV-1 infection is associated with increased permeability
of the intestinal tract, we first evaluated whether HIV-1 Nef affects
the permeability of polarized epithelial cells. To this aim, graded
doses of exogenous Nef were added basolaterally to confluent
monolayers of differentiated Caco-2 cells grown in transwells, for
48 h. To test whether Nef impacts on monolayer permeability,
FITC-dextran was added in the apical compartment and after 3 h
the fluorescence intensity was measured in the basolateral
compartment. As shown in Fig. 1A, untreated Caco-2 cell
monolayers were not readily permeable to FITC-dextran while
Nef significantly up-regulated epithelial monolayer permeability,
showing the highest tracer flux at 0.1 mg/ml. Boiled Nef and
NefF12, used as negative controls, did not modulate epithelial
monolayer permeability, confirming that the observed effect was
not due to bacterial expression or purification procedure.
In a second set of experiments we examined whether the
significative effect obtained with the recombinant Nef protein can
be confirmed with a lower dose of native Nef protein, using
supernatants from Nef-transfected 293T cells. Interestingly, we
found that supernatants from trasfected cells, containing 0.01 mg/
ml Nef, significantly up-regulated epithelial monolayer permeabil-
ity respect to supernatants of mock-transfected 293T cells (Fig. 1B).
Since the advanced stages of HIV infection are characterized by
chronic inflammation of the GI tract, we evaluated the effect of
Nef on Caco-2 cells exposed to IFN-c inflammatory mediator
(Fig. 1C). As expected, upon 48 h treatment with IFN-c the
monolayer become more permeable showing a significant increase
in the tracer flux respect to untreated Caco-2 cells. Notably, Nef
partially abrogated the effect of IFN-c, showing a significant
reduction in the tracer flux respect to IFN-c. Preincubation of Nef
with anti-Nef mAb, but not with anti-Tat mAb, abrogated the
effect of Nef, confirming that the Nef-induced modulation of
monolayer permeability was indeed a Nef-specific effect.
Next, to quantify the movement of ions across the paracellular
pathway, we evaluated the effect of Nef, IFN-c or their
combination, on TEER of Caco-2 cell monolayer. As shown in
Fig. 1 D, Nef did not significantly modulate the TEER, while IFN-
c reduced the TEER at all times analyzed, and significantly at
48 h (p,0.05) compared to untreated cells (medium). As already
observed in tracer flux assay, the addition of Nef abrogated the
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similar to those of untreated cells.
HIV-1 Nef affects the expression and localization of tight
junction proteins
Since TJ regulate paracellular permeability, we examined the
effect of Nef, IFN-c or their combination on the expression of two
TJ proteins, ZO1 and occludin. To this aim, Caco-2 cells were left
untreated or were treated with Nef, IFN-c or their combination
and immunoblot analyses were performed after 48 h. Densito-
metric analysis shows that Nef induced a 1.25- and 1.7-fold
reduction in occludin and ZO1 expression level respectively, while
IFN-c induced a 2.5- and 1.5-fold reduction, respectively. Notably,
using the combination, occludin and ZO1 expression levels were
comparable to that obtained in lysates from Nef-treated
monolayers (Fig. 2A,B).
Next, we analysed the cellular localization of ZO1 protein by
immunofluorescence (Fig. 2C). As expected, localization of ZO1
showed strong peripheral labelling in untreated Caco-2 cells. Nef
treatment reduced the intensity of ZO1 staining at cell-to-cell
contacts. No increase of immunofluorescence signal was observed
inside the cells, confirming that Nef down-regulated ZO-1
expression. Furthermore, Nef-treated cells appeared morpholog-
ically altered with irregular contours. Treatment of monolayers
with IFN-c caused a disturbance in the continuity of ZO1
localization at the cellular borders; the intensity of staining for
ZO1 was also reduced and intracellular pools of ZO1 were
apparent. To be noted that Nef partially prevented the IFN-c
Figure 1. Effect of HIV-1 Nef on paracellular flux of FITC-dextran and transepithelial electrical resistance (TEER) in untreated or IFN-
c treated intestinal epithelial cell monolayer. (A) Caco-2 cells were grown and differentiated on inserts and then left untreated (medium) or
treated with graded amounts of Nef (ranging from 0.01 to 1 mg/ml), boiled Nef (0.1 mg/ml, bNef) or NefF12 (0.1 mg/ml) for 48 h. FITC-dextran (FITC-DX)
was added in the apical compartment and after 3 h, the fluorescence intensity was measured in the basolateral compartment. Data represent means
6 SEM of 3 independent experiments in duplicate. F.I. fold increase. (B) Caco-2 cells were treated for 48 h with supernatants from 293T cells
transfected with either a pcDNA3.1 vector expressing wt Nef HIV-1 (SN wt Nef, containing 0.01 mg/ml Nef), or with the vector alone (SN mock). The
amount of Nef in supernatants was estimated by semi-quantitative anti-Nef Western blot assay against quantified amounts of recombinant Nef. (C)
Caco-2 cells were left untreated or treated with Nef (0.1 mg/ml), IFN-c (600 U/ml) or their combination for 48 h. Nef and IFN-c were preincubated with
an anti-Nef mAb (10 mg/ml) or anti-Tat mAb (10 mg/ml) for 1 h at 37uC and then added to Caco-2 cells for 48 h. Means 6 SEM from 4 independent
experiments in duplicate, are shown. (D) Caco-2 cells were cultured on filter inserts for 21 days and then left untreated (medium #) or treated with
Nef (0.1 mg/ml &), IFN-c (600 U/ml m) or IFN-c/Nef (D). The TEER values were measured at the indicated time points and were normalized with values
obtained at the start point of the analysis. Data represent means 6 SEM of 8 independent experiments in duplicate. *p,0.05 vs medium;
#p,0.05 vs
IFN-c;
Dp,0.05 vs Nef.
doi:10.1371/journal.pone.0023442.g001
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protein.
HIV-1 Nef is taken up by Caco-2 cells
The uptakeofNefby Caco-2 cellswasmonitored after1, 3,6 and
24 h of treatment in absence or presence of IFN-c. As shown in
Fig. 3 Nef uptake was already detectable after 1 h of treatment,
independently from IFN-c treatment, appearing as a diffuse
intracytoplasmatic positivity. In the absence of IFN-c, the level of
intracellular staining reached the higher brightness after 3 h of
treatment,decliningwithtime and virtually disappearing after 24 h.
Interestingly, in IFN-c-treated Caco-2 cells, the level of internalized
Nef was substantially unaltered from 3 h up to 6 h, and an intense
fluorescence was still retained after 24 h of treatment.
HIV-1 Nef inhibits IFN-c-induced apoptosis
Since IFN-c is known to compromise barrier function and to
induce apoptosis [28], we examined whether Nef, alone or in
combination with IFN-c, affects Caco-2 cell apoptosis. As shown
in Fig. 4, exposure of monolayers to Nef for 24 h did not induce
Caco-2 cell apoptosis compared to untreated Caco-2 cells. As
expected, incubation with IFN-c significantly increased the
percentage of apoptotic cells respect to untreated and Nef-treated
Caco-2 cells. Interestingly, co-incubation of IFN-c and Nef did not
increase the percentage of apoptotic cells respect to untreated cells.
HIV-1 Nef affects cytokine and chemokine production by
Caco-2 cells
In response to tissue damage, infection or exposure to antigens,
EC release inflammatory cytokines that can directly affect mucosal
integrity. We therefore examined the cytokine secretion profile of
Caco-2 cells after 48 h of treatment with Nef, IFN-c or their
combination.
As shown in Fig. 5, Nef significantly up-regulated TNF-a
secretion in a dose dependent manner, while bNef and NefF12 did
not exert any effect. Preincubation of Nef with anti-Nef mAb, but
not with anti-Tat mAb, abrogated the effect of Nef used alone or
in combination with IFN-c.
In addition, following Nef treatment there was a significant
increase in IL-6 and MIP-3a release, while IL-10 was significantly
down-regulated.
Exposure of Caco-2 cells to IFN-c induced a significant up-
regulation of TNF-a production and a significant down-regulation
of IL-10, while did not alter IL-6, MIP-3a and IL-8 secretion.
Notably, Nef abrogated the IFN-c-induced up-regulation of
TNF-a production and the IFN-c-induced down-regulation of IL-
10 production. The simultaneous exposure to Nef and IFN-c did
not affect cytokine and chemokine secretion respect to untreated
cells.
HIV-1 Nef inhibits the IFN-c-induced arachidonic acid
cascade
Since arachidonic acid-derived eicosanoids exert important
roles in immunophatology and in inflammation, we examined
whether Nef, alone or in combination with IFN-c, interferes with
arachidonic acid (AA) cascade.
As shown in Fig. 6A, neither Nef nor IFN-c or their
combination modulated the activity of cPLA2, a key enzyme in
prostaglandin production, respect to untreated cells, after 4 h of
treatment.
Figure 2. Effect of HIV-1 Nef on tight junction protein expression and localization in untreated or IFN-c treated intestinal epithelial
cell monolayer. (A) Differentiated Caco-2 cells were left untreated (medium) or were treated for 48 h with Nef, IFN-c or their combination. Cells
were then lysed and proteins were probed on Western blots with anti-occludin or anti-ZO1 mAbs. (B) The expression of the proteins was estimated
by densitometry after normalization with the b-actin signal. Data represent values from 1 experiment representative of 3 performed. (C)
Immunofluorescence analysis of ZO1 distribution in untreated (medium) or 48 h Nef-, IFN-c - or IFN-c/Nef- treated Caco-2 monolayers. The
experiment was repeated 3 times to ensure reproducibility.
doi:10.1371/journal.pone.0023442.g002
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involved in the conversion of arachidonic acid to prostaglandin.
The results obtained indicate that Nef and IFN-c did not modulate
COX-2 expression after 24 h of treatment. Interestingly, co-
incubation of IFN-c and Nef down-regulated COX-2 expression
respect to untreated, Nef- or IFN-c-treated cells (Fig. 6B).
Finally, we measured the biologically active product PGE2,
after 24 h of Nef, IFN-c or IFN-c/Nef treatment. We found that
Nef did not affect PGE2 release. On the other hand, IFN-c
significantly up-regulated PGE2 release. In agreement with COX-
2 reduction, Nef abrogated the IFN-c-induced up-regulation of
PGE2 release (Fig. 6C).
Discussion
In the present study, we demonstrate that exogenous HIV-1 Nef
increases intestinal epithelial tight junction permeability and
abrogates the effects induced by IFN-c on intestinal EC monolayer
permeability and cell viability inhibiting the IFN-c induced
arachidonic acid cascade.
We investigated the effect of Nef exposure on Caco-2 cell line,
as a model for GI tracts. Caco-2 cells undergo a gradual
differentiation process that takes place spontaneously once
confluence has been reached, characterized by the acquisition of
morphological and functional polarity highly comparable to those
of mature enterocytes. Caco-2 cells express functional tight
junctions, brush border characteristics and biotrasformation
enzymes, and their differentiation process is thought to reflect
the maturation occurring in vivo along the crypt-villus axis, which
makes Caco-2 probably the best in vitro model of human
enterocytes currently available [29].
Increased mucosal inflammation is an important feature of
acute HIV infection and is associated with lower systemic CD4
+ T
cell counts. HIV-1 in line with active intestinal bowel disease (IBD)
is associated with a strong inflammatory response in the gut lamina
propria and a number of parallels are observed between HIV and
IBD in terms of gut disease, such as an increased intestinal
permeability and enteropathy [3]. IFN-c accurately mimics
intestinal inflammatory process and a number of published studies
employ this cytokine as a valid and consistent in vitro model of the
physio-pathological behaviour of enterocytes during the acute
phase of IBD [28,30,31]. IFN-c is a major interplayer of
inflammation and immune responses, and has been reported to
have suppressive/enhancing effects on HIV which may depend on
cell type or activation status [32-34]. Thus, in the present study,
we analyzed the effect of Nef on both unstimulated and IFN-c-
stimulated Caco-2 cells, to mimic the early phase of infection and
the inflammatory acute phase. We found that IFN-c reduced
transepithelial resistance, a measure of monolayer integrity. The
decrease in TEER correlated with increased permeability and
disruption of tight junction proteins. Our data confirm previous
observations that clearly established that proinflammatory cyto-
kines are implicated in damage to the intestinal/epithelial barrier
function [28,30,31]. Similarly, but to a lesser extent, Nef increased
intestinal epithelial tight junction permeability. Interestingly, the
IFN-c-induced impairment of monolayer integrity was partially
restored when Caco-2 cells are challenged simultaneously with Nef
and IFN-c, probably due to mutual cross-regulation of signalling
Figure 3. HIV-1 Nef uptake in intestinal epithelial cells. Differentiated Caco-2 cells were left untreated (medium) or were treated for 1, 3, 6 and
24 h with biotynilated-Nef alone or in combination with IFN-c. Nef uptake was analyzed by CLSM (central optical sections). Nuclei are reported in blue
(DAPI). Nef was detected as a diffuse intracytoplasmatic positivity (green). Scale bar, 20 mm. Panels are representative of 3 independent experiments.
doi:10.1371/journal.pone.0023442.g003
Figure 4. Effect of HIV-1 Nef on untreated or IFN-c treated
intestinal epithelial cell apoptosis. Differentiated Caco-2 cells were
left untreated (medium) or were treated for 48 h with Nef, IFN-c or their
combination. Quantitative evaluation of apoptosis was performed by
flow cytometry measuring co-staining of annexin V and propidium
iodide. Means 6 SEM from 5 independent experiments in duplicate, are
shown. *p,0.05 vs medium;
#p,0.05 vs IFN-c;
Dp,0.05 vs Nef.
doi:10.1371/journal.pone.0023442.g004
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Nef was not able to restore the impairment of epithelial barrier
integrity induced by high dose of IFN-c (1000 U/ml) (data not
shown). In addition, Nef did not exert any effect if Caco-2 cell
monolayer was pre-treated with IFN-c (data not shown). Thus, it
might be assumed that Nef acts differently during the early, acute
and chronic phases of HIV-infection, characterized by different
inflammatory cytokine profile.
Despite numerous reports describe how HIV-1 Nef affects
immune cells, the effect of Nef on EC remains unknown. In this
context, we have previously demonstrated that exogenous Nef
regulates co-receptor expression and cytokine secretion in human
bladder, laryngeal and intestinal epithelial cell lines, depending on
the anatomical derivation of the cells or the inflammatory status
[35]. Other studies reported that Nef induces proliferation and de-
differentiation of podocytes, suggesting that it may have a critical
role in the pathogenesis of HIV-associated nephropathy [36–39].
The present data indicate that Nef, targeting EC, may also play a
crucial role in AIDS-related gastrointestinal dysfunction.
So far, most of the activities of Nef have been attributed to the
intracellular expression of the protein or its association with
virions. However, Nef is known to be secreted from infected cells
[16] in association with small membrane-bound vescicles [17,18].
We found that purified exogenous Nef is efficiently taken up by
unstimulated and IFN-c stimulated Caco-2 cells and, indepen-
dently from IFN-c treatment, Nef appeared as a diffuse
intracytoplasmatic positivity. Interestingly, in IFN-c-treated
Caco-2 cells, internalized Nef was still retained after 24 h of
treatment suggesting that IFN-c may prolong Nef up-take or its
intracellular survival.
Fuji et al reported that a high percentage of sera from HIV-1-
infected individuals contained soluble Nef at a concentration of 1–
10 ng/ml, while patient’s sera in which Nef was not detectable
contained high titers of anti-Nef antibodies [16]. This concentra-
tion may be higher in the gut-associated lymphoid tissue (GALT)
where virion-trapping dendritic cells, as well as virion-infected
CD4
+ T cells and macrophages, are densely packed [40]. Thus,
the effective Nef concentration for epithelial cell impairment could
be reached in vivo. Notably, our results were confirmed with a
lower dose of native Nef protein secreted in the supernatants of
Nef transfected 293T cells.
Ndolo et al [41] reported that GALT is an early site for strong
positive selection for functional full-length Nef. GALT is an early
Figure 5. Effect of HIV-1 Nef on cytokine and chemokine secretion by untreated or IFN-c treated intestinal epithelial cells. Caco-2
cells were grown and differentiated on inserts and then left untreated (medium) or treated with graded amounts of Nef (ranging from 0.01 to 1 mg/
ml), boiled Nef (0.1 mg/ml, bNef) or NefF12 (0.1 mg/ml). After 48 h supernatants were harvested from the basolateral chambers and tested for
cytokines (TNF-a, IL-6, IL-10) and chemokines (MIP-3a, IL-8) by ELISA. In some experiments Nef and IFN-c were preincubated with an anti-Nef mAb
(10 mg/ml) or anti-Tat mAb (10 mg/ml) for 1 h at 37uC and then added to Caco-2 cells for 48 h. Results are expressed as pg/ml and are means 6 SEM
from 4 independent experiments in duplicate. *p,0.05 vs medium;
#p,0.05 vs IFN-c;
Dp,0.05 vs Nef.
doi:10.1371/journal.pone.0023442.g005
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reservoir, even in patients receiving HAART. The selective loss of
intestinal CD4
+ T cells is likely to explain, together with mucosal
barrier breakdown, the preponderance of opportunistic infections
at mucosal sites [42]. Thus, the study of the events occurring at
mucosal sites are relevant to a better understanding of AIDS
pathogenesis and to help the development of preventive or
therapeutic vaccines against HIV that may be administered by the
mucosal route. The goal would be to prevent or reduce the
propagation of HIV at mucosal surfaces to restore the immuno-
logical and epithelial integrity of the mucosal barrier and to block
pathways through which microbial products cause systemic
immune activation [43,44]. In this context, our data may provide
new directions for therapeutic interventions. Notably, the Nef-
induced increase in intestinal permeability might favour its uptake
during immunization procedure, while its ability to partially
restore epithelial barrier integrity in the presence of IFN-c and to
prevent the IFN-c-induced apoptosis might counteract gastroin-
testinal dysfunction in AIDS patients.
Besides their barrier function, intestinal EC participate in
mucosal immune and inflammatory reactions secreting cytokines
and chemokines. In health, the GI tract maintains a balance
between immune tolerance and rapid responsiveness [45,46],
which is perturbed in HIV infection [4].
It is well known that Nef induces cytokine and chemokine
secretion by monocytes/macrophages [47–49] and DC [19]
interfering with cellular signal transduction pathways [12]. This
study provides evidence that intestinal EC respond to Nef,
producing increased level of TNF-a, IL-6 and MIP-3a and
decreased level of IL-10. Cytokine release, as well as the down-
regulation of IL-10 production, might favour activation of T cells,
rendering them permissive for the replication of the virus [50] and
activating HIV-1 replication in latently infected cells [51]. In
addition, we found that Nef inhibits the IFN-c induced AA
cascade. Caco-2 cell differentiation is characterized by an increase
in polyunsatured fatty acids, such as AA, critical in immunity and
inflammation [52,53]. We demonstrated that Nef abrogated the
IFN-c-induced up-regulation of PGE2 release, by a reduction of
COX-2 expression level. The IFN-c-induced up-regulation of
PGE2 release was not associated with an increased COX-2
expression, suggesting that IFN-c might increase COX-2 activity
instead of its expression levels or might act further downstream,
exerting a positive regulatory role at the level of prostaglandin E
synthase expression.
These results may be relevant, considering that local inflam-
matory response may be both harmful and helpful for viral
dissemination. While recruiting HIV-susceptible CD4
+ T cells to
the site of infection, cytokines/chemokines also lead to increased
recruitment of HIV-specific CD8
+ T cells. Thus, in the early step
after viral transmission, HIV-1 might benefit from the balance
between inflammation and protective immunity induced by Nef,
creating a microenvironment that favours viral replication.
Figure 6. Effect of HIV-1 Nef on arachidonic acid cascade in untreated or IFN-c treated intestinal epithelial cells. Differentiated Caco-2
cells were left untreated (medium) or were treated with Nef, IFN-c or their combination. (A) After 4 h cPLA2 enzyme activity was assessed in cell
lysates. Results are expressed as nmol/min/mg protein and are means 6 SEM from 5 independent experiments in duplicate. (B) After 24 h, proteins
were probed on Western blots with anti-COX-2 polyclonal antibody. The expression of COX-2 was estimated by densitometry after normalization with
the b-actin signal. Blots are representative of three independent experiments. (C) After 24 h cell supernatants were harvested and PGE2
concentrations were measured by ELISA, according the manufacturer’s instruction. Results are expressed as pg/ml and are means 6 SEM from 4
independent experiments in duplicate. *p,0.05 vs medium;
#p,0.05 vs IFN-c;
Dp,0.05 vs Nef.
doi:10.1371/journal.pone.0023442.g006
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c-induced impairment of intestinal epithelial cells, possibly
prolonging cell survival and allowing the accumulation of viral
particles before cell destruction and virus release. This is relevant
considering that most viruses have evolved strategies to defend
themselves against host IFN responses [54].
A better understanding of the role of Nef in HIV-1-related
intestinal dysfunction will help in the development of novel
strategies to provide protection against the first exposure to the
virus and against the subsequent long-lasting mucosal damage.
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